• Corpus ID: 52229827

HMGB 1 influencing invasion , migration and proliferation abilities of breast cancer cells via PI 3 K / AKT signaling pathway

@inproceedings{Yin2017HMGB1I,
  title={HMGB 1 influencing invasion , migration and proliferation abilities of breast cancer cells via PI 3 K / AKT signaling pathway},
  author={Xiao-Cheng Yin and Hao Sun},
  year={2017}
}
Objective: To investigate the effect of HMGB1 on invasion and migration of human breast cancer cells through the PI3K/AKT signaling pathway and the related mechanism. Methods: The MCF-7 cells were selected from those breast cancer cell lines with high expression of HMGB1 by Western blotting; HMGB1 knockdown lentivirus (LV3-HMGB1) was used to silence the expression of HMGB1; efficiency of LV3-HMGB1 silencing was measured by GFP fluorescence and Western blotting; effect of silencing HMGB1 on… 
ijcem.com

Figures from this paper

31 References

HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells

High-mobility group box 1 (HMGB1), the best characterized damage-associated molecular pattern, was released from leukemia cell lines after chemotherapy-induced cytotoxicity and activated autophagy to protect against injury and suggest that HMGB1 release after chemotherapy is a critical regulator of autophamy and a potential drug target for therapeutic interventions in leukemia.

Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer.

Sensitization of TNF-induced cytotoxicity in lung cancer cells by concurrent suppression of the NF-kappaB and Akt pathways.

Ethyl pyruvate administration inhibits hepatic tumor growth

EP inhibition of tumor growth in the liver was mediated by tumor (induction of apoptosis) and host (decreased inflammation) effects, suggesting that EP administration may have a therapeutic role in the treatment of cancer in conjunction with other therapeutic agents.

High-mobility group box 1 and cancer.

Akt is frequently activated in HER2/neu‐positive breast cancers and associated with poor prognosis among hormone‐treated patients

Investigation of the relationship between activation of Akt and clinicopathologic variables including hormone receptor and HER2/neu status suggests that inhibition of the Akt signaling pathway may increase the efficacy of hormone therapy and improve the prognosis of patients who receive adjuvant hormone therapy.

Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma

The authors investigated phosphorylated Akt (Ser473) in colorectal carcinomas to reveal the role of PI3K signaling during the development of coloreCTal carcinoma.

Genomic Determinants of PI3K Pathway Inhibitor Response in Cancer

The genomic determinants of response to PI3K, dual PI3k/mechanistic target of rapamycin (mTOR), mTOR, and AKT inhibitors in cancer identified in preclinical models and clinical trials to date, and the development of molecular tools for the stratification of cancer patients are focused on.

Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer

In addition to the common risk factors such as larger tumor size, lymph node involvement, estrogen receptor/progesterone receptor-negative tumors, and HER2/neu-positive tumors, overexpression of pAkt significantly was associated with a decrease in 5-year DFS.

PI3K pathway activation in breast cancer is associated with the basal‐like phenotype and cancer‐specific mortality

It is concluded that >70% of breast cancers have an alteration in at least 1 component of the PI3K pathway and this might be exploited to therapeutic advantage especially in “basal‐like” cancers.